Effect of polybasic antibiotics and sulfaguanidine on absorption and excretion of cholesterol and bile salts.
D000814:Aniline Compounds / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000924:Anticholesteremic Agents; D001647:Bile Acids and Salts / Q000032:analysis / Q000378:metabolism*; D002645:Chickens; D002784:Cholesterol / Q000097:blood / Q000378:metabolism*; D002792:Cholestyramine Resin / Q000494:pharmacology; D004347:Drug Interactions; D005243:Feces / Q000032:analysis; D005856:Germ-Free Life / Q000187:drug effects; D006146:Guanidines / Q000494:pharmacology*; D006937:Hypercholesterolemia; D007408:Intestinal Absorption / Q000187:drug effects*; D008099:Liver / Q000032:analysis; D051379:Mice; D009355:Neomycin / Q000494:pharmacology; D051381:Rats; D013307:Streptomycin / Q000494:pharmacology; D013414:Sulfaguanidine / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology*
D000814:Aniline Compounds; D000900:Anti-Bacterial Agents; D000924:Anticholesteremic Agents; D001647:Bile Acids and Salts; D006146:Guanidines; D013449:Sulfonamides; D002792:Cholestyramine Resin; D013414:Sulfaguanidine; D002784:Cholesterol; D009355:Neomycin; D013307:Streptomycin